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1. Introduction 
a2-Macroglobulin (cr2M) is a large protein found in 
high amounts in plasma and other body fluids of 
many vertebrates. Many cell types have specific recep- 
tors for azM and rapidly internalize it after binding 
[l-l 11. Fluorescence and electron microscopic data 
indicate that prior to binding CQM, receptors are ran- 
domly distributed on the cell surface [9]. The cuzM- 
receptors randomly diffuse about in the cell mem- 
brane [12], bind azM, and become trapped in clusters 
in coated pits [7-lo]. After accumulation in coated 
pits, oc,M rapidly enters the cells and is soon found in 
uncoated vesicles termed receptosomes [8]. 
The entry of azM is inhibited by a variety of com- 
pounds. Among these are primary amines such as 
methylamine and dansylcadaverine, and bacitracin 
[ 13 -161. Because these compounds are inhibitors of 
cellular transglutaminase activity, we have suggested 
that a transglutaminase-like nzyme participates in 
the internalization process [13,14,16]. 
The binding and internalization of CQM by intact 
cultured fibroblasts have also been studied using 
‘2SI-~ZM [ 11 151 at 4°C. Two classes of binding sites 
have been idlntified [ 111. A high affinity class (Kd 
0.2 nM) that is present in small numbers (10 OOO/cell) 
[ 11 ,I 51 and a low affinity class (Kd 100 nM) that is 
present in large numbers (600 OOO/cell) [ 111. Trans- 
glutaminast inhibitors prevent binding to the high 
affinity class [ 11 ,I S] but now the low affinity class 
[ 111. We have suggested that the high affinity class 
represents receptor-l&and complexes clustered in 
coated pits because electron microscopic studies 
showed that methylamine prevented clustering of 
receptor-ligand complexes in these structures [13]. 
An alternative suggestion has been that the transglu- 
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taminase inhibitors act to prevent receptor recycling 
[ 151. To distinguish between a direct effect on bind- 
ing and an effect on receptor recycling we have stud- 
ied the effect of bacitracin on CQM binding to isolated 
plasma membranes in which receptor recycling can- 
not occur. 
2. Experimental 
For morphologic studies Swiss 3T3 cells were 
incubated at 4°C for 30 min with 30 pg @*M/ml with 
or without 6 mg/ml bacitracin (Sigma). Then cells 
were fixed, sectioned and viewed by electron micros- 
copy as in [ 131. 
cw,M was prepared from whole human plasma as in 
[9,17]. azM was iodinated using either the chlor- 
amine-T procedure [6] at spec. act. 4 X 10’ cpm/pg 
or the Bolton-Hunter reagent (New England Nuclear) 
at spec. act. 5 X lo6 cpm/pg). 
Purified plasma membranes were prepared from 
Balb/c 3T3 fibroblasts as in [ 181. About 10% of the 
cellular protein was recovered in the plasma mem- 
brane fraction. The membrane pellet was diluted to 
1 mg protein/ml in 10 mM Tris (pH 7.8), 1 mM 
EDTA, 1% Trasylol and frozen in aliquots. Before 
each experiment membranes were thawed, pelleted, 
and resuspended in 20 mM Hepes (pH 7.4) buffer. 
These plasma membranes contained both classes of 
binding sites for ‘251-~ZM. 
Bacitracin was dissolved in Hz0 at 100 mg/ml. For 
binding studies, 100 fl membrane suspension were 
preincubated for 20 min at 23°C with 1.5 mM CaCl*, 
with or without bacitracin (2 mg/ml). Then BSA (to 
yield 2 mg/ml) and 1251-a2M were added. The total 
volume of each incubation was always 200 ~1. Bind- 
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ing was carried out at 23OC and then the suspensions 
were cooled on ice. Membranes were pelleted at 4’C 
by centrifugation for 2 rnin in an Eppendorf centri- 
fuge (model 54 12). The pellet was resuspended at 
4°C in Hepes (pH 7.4) containing 1 .S mM CaCls, cen- 
trifuged, and radioactivity in the pellet determined 
using an LKB mini-gam~~ounter. 
Data from saturation analyses of binding were 
graphed by the Scatchard method [ 193 and analyzed 
by a computer program called SCATFIT [20]. This 
program employs a least square analysis and deter- 
mines the number of classes of binding sites which 
best fit the data. The program also determines the 
parameters of each class of binding sites: the K, and 
the capacity. 
3, Results and discussion 
3.I. in~~b~~~5tl of ~i~ste~~g of ~~~-,-rece~tor corn- 
plexes in coated pits by bac~rr~ei~ 
We have shown by electron microscopy that meth- 
ylamine blocks clustering of arzM-receptor com- 
plexes in coated pits. To be certain that bacitracin has 
the same effect, cells were incubated at 4°C with 
a?M, labeled with peroxidase-anti-azM and visualized 
by electron microscopy. Peroxidase reaction product 
was seen concentrated in clathrin~oated pits (fig.1). 
Bacitracin reduced the appearance of peroxidase reac- 
tion product in coated pits (fig.1 ). Experiments were 
next carried out to determine if a direct effect of 
bacitracin could be detected in isolated plasma 
membranes. 
3.2. Direct inhibition of high affinity binding sites in 
Plasma membranes from Balbjc cells were incu- 
bated with 0.03 pg-3 mg asM/ml (fig.2). When the 
data were graphed by the Scatchard method [ 191 and 
analyzed by computer [ZO], a model consisting of 
2 classes of binding sites best fit the data. One class 
had a high affinity (0.20 pg/rnl or 0.24 nM) and a low 
capacity (0.4 Erg/ml protein). The other class had a 
low af~nity (60 ~g/rnI or 71 n&f) and a high capacity 
(30 pgjrng protein). The affinities of these two 
classes of sites are similar to those using 4°C incuba- 
tions of 12sI-~ZM with intact fibroblasts [ 1 I ,I 51. 
Both high and low affinity sites were recovered in 
80% yield. In data to be presented elsewhere, we 
demonstrate that these binding sites have other prop- 
erties in common with those of intact Bbroblasts; 
binding is strongly dependent upon the presence of 
Ca”‘, and high affinity binding is selectively reduced 
by dansylcadaverine, another inhibitor of transglu- 
taminase. 
In the presence of 2 mg bacitracinlml the high 
Fig.1. Swiss 3T3 fibroblasts were incubated with or,M (30 @g/ml) at 4°C for 3U min in the absence (A) or presence of fB) bacitra- 
tin. Cells were then washed in the presence of bacitracin and incubated with peroxidase-labeled antibodies followed by fixation at 
4°C. In (A) receptor-a,M complexes are found clustered in coated pits. In (B) the a,M does not cluster in coated pits. The small 
amounts of isolated peroxidase reaction product along the membrane is consistent with the diffuse distribution of ol,M on the 
majority of the eel1 membrane (Mag: x 108 000; bar = 0.1 pm). 
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Fig.2. Concentration dependence of binding of lzSI-o,M Balb/c plasma membranes were incubated with various concentrations of . 
‘25I-o M + 3 mg/ml ar,M at 23°C for 40 min. Parallel incubations had been preincubated 10 min at 23°C with 2 mg/ml bacitracin. 
Bindiig data are plotted (A) as a saturation curve or (B) by the Scatchard method [ 191 and analyzed by computer [ 201 (see sec- 
tion 2): (0) bacitracin present; (*) bacitracin absent. Data are pooled from 2 separate expt. 
affinity binding was reduced and primarily the low 
affinity class was detected (& = 40 Pg/ml; capacity 
25 /Is/ml) protein (fig.2). We had observed usingintact 
fibroblasts that high-affinity binding of 1251-~2M, as 
well as internalization, was much reduced by bacitra- 
tin [ 111. In [ 151, binding of 02M to high affinity 
receptors of intact normal human fibroblasts was 
blocked by another transglutaminase inhibitor, dan- 
sylcadaverine, and this effect was suggested to be due 
to an intracellular blockade of receptor ‘recycling’ 
[ 151. It is not known if they failed to detect the 
majority of receptors, those with a lower affinity, or 
if normal human fibroblasts contain only high affin- 
ity sites. 
Because recycling of receptors into the cell cannot 
occur in isolated membranes, this study shows that a 
transglutaminase inhibitor, bacitracin, directly blocks 
binding to high-affinity sites in plasma membranes of 
cultured fibroblasts. This supports a model in which a 
transglutaminase-like activity in the plasma mem- 
brane is required for conversion of low affinity recep- 
tors to high affinity receptors in the membrane. We 
suggest his occurs when cu,M receptor complexes 
cluster in coated pits. Our data does not support a 
model in which the inhibitors only affect receptor 
recycling. 
The importance of this study is that for the first 
time a compound that inhibits internalization of o2M 
has been shown to have a direct action on isolated 
plasma membranes. This study indicates that the 
transglutaminase-like activity postulated to be required 
for internalization is located in plasma membranes. 
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